1. Clinical & Scientific Overview
Ipratropium Bromide (Alone & in Combination with Levosalbutamol / Salbutamol) (TIP-MED-000170, Reference Code [9.6]) is classified under
Respiratory, Asthma, COPD & Allergy Medicines (Ch 09) as a Short-Acting Muscarinic Antagonist (SAMA; 6-to-8 Hour Anticholinergic Bronchodilator).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Representative Indian Market Examples (Edition 2.7 Ch 09 [9.6], p. 116): Alone: Ipravent (Cipla—Inhaler, Rotacaps, Respules), Iprazest; Widely dispensed in SAMA + SABA Combination (Ipratropium + Levosalbutamol / Salbutamol): Duolin (Cipla—Inhaler, Rotacaps, Respules), Combimist (Zydus) — Strengths & Dosage Forms: Ipravent pMDI: 20 mcg/puff; Ipravent Respules: 500 mcg/2 mL. Duolin pMDI: Ipratropium 20 mcg + Levosalbutamol 50 mcg/puff; Duolin Respules (Nebuliser): Ipratropium 500 mcg + Levosalbutamol 1.25 mg / 2.5 mL (or 3 mL)
Ipravent pMDI: 20 mcg/puff; Ipravent Respules: 500 mcg/2 mL. Duolin pMDI: Ipratropium 20 mcg + Levosalbutamol 50 mcg/puff; Duolin Respules (Nebuliser): Ipratropium 500 mcg + Levosalbutamol 1.25 mg / 2.5 mL (or 3 mL)
3. Mechanism of Action & Pharmacodynamics
Short-Acting Muscarinic Antagonist (SAMA; 6-to-8 Hour Anticholinergic Bronchodilator) acting on target receptor/enzyme pathways in Respiratory, Asthma, COPD & Allergy Medicines (Ch 09): clinical efficacy is mediated via Short-Acting Muscarinic Antagonist (SAMA; 6-to-8 Hour Anticholinergic Bronchodilator) for Acute exacerbations of COPD and severe acute asthma (SAMA + SABA nebulisation/inhaler provides synergistic bronchodilation by simultaneously blocking vagal cholinergic bronchoconstriction and stimulating beta-2 relaxation); symptomatic relief in COPD..
4. Therapeutic Indications & Evidence-Supported Uses
- Acute exacerbations of COPD and severe acute asthma (SAMA + SABA nebulisation/inhaler provides synergistic bronchodilation by simultaneously blocking vagal cholinergic bronchoconstriction and stimulating beta-2 relaxation)
- symptomatic relief in COPD
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: pMDI: 2 puffs 3 to 4 times daily (every 6–8 hours) or SOS. Nebuliser Respules (Duolin / Ipravent): 1 respule (2.5–3 mL) nebulised every 6 to 8 hours (or every 20 min x 3 doses in acute severe emergency asthma/COPD). Follow physician prescription.
Administration & Meal Timing: Inhaled: Independent of food. | Every 6 to 8 hours during acute exacerbations or SOS.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal & Hepatic: Very low systemic absorption (<10%) from inhaled ipratropium quaternary ammonium structure; no renal or hepatic dose adjustment required.
Renal & Hepatic: Very low systemic absorption (<10%) from inhaled ipratropium quaternary ammonium structure; no renal or hepatic dose adjustment required.
Renal & Hepatic: Very low systemic absorption (<10%) from inhaled ipratropium quaternary ammonium structure; no renal or hepatic dose adjustment required.
7. Contraindications, Precautions & High-Risk Warnings
- Same anticholinergic precautions as Tiotropium: Acute Angle-Closure Glaucoma if nebuliser mist enters the eyes! Caution in Benign Prostatic Hyperplasia (BPH) and bladder outflow obstruction.
Key Clinical Precautions: Renal & Hepatic: Very low systemic absorption (<10%) from inhaled ipratropium quaternary ammonium structure; no renal or hepatic dose adjustment required.
8. Adverse Effects Profile
- Dry mouth, bitter metallic taste, throat irritation, cough, headache; if using Duolin (contains levosalbutamol): mild hand tremor and tachycardia.
- Acute Angle-Closure Glaucoma and Mydriasis ('Nebuliser Anisocoria'—unilateral dilated pupil when a poorly fitting nebuliser mask leaks ipratropium mist into one eye!), acute urinary retention in elderly men with BPH, paradoxical bronchospasm, supraventricular tachycardia.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Avoid combining regular daily Ipratropium/Duolin with a Long-Acting Muscarinic Antagonist (LAMA: Tiotropium [Tiova], Glycopyrronium, Umeclidinium) due to duplicate muscarinic receptor blockade! Additive anticholinergic side effects with bladder antimuscarinics (solifenacin/oxybutynin), TCAs, and antihistamines
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: CRITICAL NEBULISER MASK EYE WARNING FOR DUOLIN / IPRAVENT: When elderly patients nebulise Duolin or Ipravent respules at home using a face mask, vapour leaking upward over the bridge of the nose directly hits the eyes—causing blurred vision, a fixed dilated pupil, or an acute glaucoma crisis! Instruct the patient/caregiver: 'Use a T-piece mouthpiece if possible; if using a face mask, pull the strap snug over the nose bridge and keep both eyes tightly closed throughout the 10-minute nebulisation, then wash the face afterward!'
- Meal & Clock Timing Instruction: Inhaled: Independent of food. (Every 6 to 8 hours during acute exacerbations or SOS.)
- Missed Dose Protocol: Used SOS or 6–8 hourly; never double.
- Geriatric Dispensing Pearl: Verify whether the patient is also taking daily Tiova or Triohale—if they are on a daily LAMA, continuous 3-times-daily Duolin nebulisation after hospital discharge is redundant and precipitates urinary retention and severe dry mouth.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Ipravent pMDI: 20 mcg/puff; Ipravent Respules: 500 mcg/2 mL. Duolin pMDI: Ipratropium 20 mcg + Levosalbutamol 50 mcg/puff; Duolin Respules (Nebuliser): Ipratropium 500 mcg + Levosalbutamol 1.25 mg / 2.5 mL (or 3 mL)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 09 [9.6] (p. 116)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [9.16] N-Acetylcysteine (Oral/Inhaled Mucolytic) & Ambroxol / Bromhexine — Sulfhydryl Disulfide-Bond Mucolytic + Glutathione Precursor & Muc
- [9.17] Dextromethorphan Hydrobromide & Levodropropizine — Central Medullary Sigma-1/NMDA Cough Suppressant & Peripheral Sen
- [9.18] Fexofenadine Hydrochloride & Bilastine — Non-Sedating Second-Generation P-gp Substrate Histamine H1-Recept
- [9.19] Hydroxyzine Hydrochloride & Promethazine Theoclate / Hydrochloride — First-Generation Lipophilic Histamine H1-Receptor Inverse Agonist
